Aptinyx
company
About
Aptinyx Inc. is a biopharmaceutical company.
- 51 - 100
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $5.60M
- Industries
- Biopharma,Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Aptinyx Inc. is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication. This mechanism has applicability across a number of CNS disorders. Our goal is to rapidly advance our most promising drug candidates into clinical development for indications with high unmet medical need.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$140.60M
Aptinyx has raised a total of
$140.60M
in funding over 2 rounds. Their latest funding was raised on
Nov 3, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 3, 2022 | Grant | $5.60M | 1 |
National Institutes of Health
|
— | Detail |
| Dec 18, 2017 | Series B | $70M | 2 | — | — | Detail |
| May 10, 2016 | Series A | $65M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
3
Aptinyx is funded by 3 investors.
National Institutes of Health
and LVP Life Science Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
|
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
